Bentham Science Logo
Journal Cover

Track Your Manuscript:


Current Enzyme Inhibition

Volume 17, 3 Issues, 2021
ISSN: 1875-6662 (Online)
ISSN: 1573-4080 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Aims & Scope

Current Enzyme Inhibition aims to publish original research, full-length/mini review and letter articles in all the latest and outstanding developments on enzyme inhibition studies. The coverage includes the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Current Enzyme Inhibition is an essential journal for every pharmaceutical researcher and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Current Enzyme Inhibition

,

Volume 16

-

Number 3



Review Article (Mini-Review)



Review Article

The Role of STAT3 Signaling in Different Types of Cancers: A Comprehensive Review

, 16(3): 189 - 198

Kaviarasan Lakshmanan, Gowramma Byran*, Sravanthi Bandlamudi and Praveen Thaggikuppe Krishnamurthy


DOI: 10.2174/1573408016999200708160300






Research Article









Published Contents

Editor's Choice






Vigna unguiculata Trypsin Inhibitor: A Protein with Versatile Biological Applications

, 2018; 14(1): 75 - 84

Romana Parveen, Tooba Naz Shamsi, Sumbul Afreen, Mudsser Azam, Tasneem Fatma, Qazi Mohd. Rizwanul Haque and Sadaf Fatima*


DOI: 10.2174/1573408013666170619085504



Molecular Insight and Binding Pattern Analysis of Shikonin as a Potential VEGFR-2 Inhibitor

, 2017; 13(3): 235 - 244

Raju Dash, Md. Junaid, Nazrul Islam, Md. Forhad Chowdhury Akash, Md. Imran Khan, Md. Arifuzzaman, Mahmuda Khatun and S. M. Zahid Hosen*


DOI: 10.2174/1573408013666161227162452



Overview of the Structure and Function of Protein Kinases

, 2017; 13(2): 81 - 88

Sugunadevi Sakkiah, Guang Ping Cao, Staya P. Gupta and Keun Woo Lee*


DOI: 10.2174/1573408013666161226155608





Open Access Articles

Inhibition by Substrates of a Coniferyl Alcohol Dehydrogenase Purified from Sugarcane Stalks

, 2019; 15(3): 206 - 214

Borja Alarcón, Roberto de Armas, Carlos Vicente and María E. Legaz*




Exploring Molecular Docking Studies of Alanine Racemase Inhibitors from Elettaria cardamomum

, 2019; 15(2): 91 - 102

Rosy Kumari, Ratish Chandra Mishra, Shivani Yadav and Jaya Parkash Yadav*




Should Olanzapine be Advocated Over Conventional Anti-Emetics for the Prevention of Chemotherapy-Induced Nausea and Vomiting? An Updated Meta-Analysis of Randomized Control Trials

, 2019; 15(2): 80 - 90

Eshak Ibrahim Bahbah*, Ahmed Ramadan Abdalla, Khalid Abdelshafy, Ahmed Diaa Almohandes , Amr Menshawy, Mohamed Abd Elalem Aziz, Mahmoud Ahmed Ebada, Awad Hegab and Ahmed Negida*






Identification of New Enterococcus faecalis Peptide Deformylase Inhibitors

, 2019; 15(2): 120 - 132

Amina Merzoug*, Abdelouahab Chikhi, Abderrahmane Bensegueni, Hanane Boucherit and Sawsen Hadef




Application of Remote Ischemic Preconditioning in Patients Undergoing Chemotherapy with Anthracyclines

, 2019; 15(2): 114 - 119

Simone Meneghetti Zatta, Neif Murad, Beatriz da Costa Aguiar Alves, Ligia Ajaime Azzalis, Virginia Berlanga Campos Junqueira, Roberto Odebrecht Rocha, Marcelo Rodrigues Bacci, David Feder, Antonio Carlos Palandri Chagas, Fernando Adami and Fernando Luiz Affonso Fonseca*






High Antioxidant Capacities and Anti-inflammatory Effects of Hammada elegans Botsch. Extracts: An in vitro Assessment

, 2019; 15(1): 55 - 68

Bensafiddine Feriha, Asseli Brahim, Mahfoudi Reguia, Djeridane Amar* and Yousfi Mohamed








An Additional Method for Analyzing the Reversible Inhibition of an Enzyme Using Acid Phosphatase as a Model

, 2015; 11(2): 140 - 146

Jordan M. Baumhardt, Benjamin M. Dorsey, Craig C. McLauchlan and Marjorie A. Jones





Most Cited Articles

Review Article

Recent studies on HDAC inhibitors acting against prostate cancer

, 2020; 16(1): 74-89.

Basheerulla Shaik*, Tabassum Zafar and Satya P. Gupta


DOI: 10.2174/1573408016666200402092557



Review Article

A brief review on dual target of PARP1 and STAT3 for cancer therapy: A novel perception

, 2020; 16(2): 115-134.

Kaviarasan Lakshmanan, Gowramma Byran* and Manal Mohammed


DOI: 10.2174/1573408016666200316114209



Review Article

Recent studies on aromatase and sulfatase involved in breast cancer and their inhibitors

, 2020; 16(1): 20-44.

Subhajit Makar, Abhrajyoti Ghosh, Ashok Kumar and Sushil K. Singh*


DOI: 10.2174/1573408016666200325120248



Review Article

Role of cytochrome P450 in prostate cancer and its therapy

, 2020; 16(1): 63-73.

Rishabh Kaushik, Sheeza Khan, Meesha Sharma, Srinivasan Hemalatha, Zeba Mueed and Nitesh K. Poddar*


DOI: 10.2174/1573408016666200218122044


Review Article

Studies on structures and functions of kinases leading to prostate cancer and their inhibitors

, 2020; 16(1): 90-105.

Anantha N. Nagappa, Shvetank Bhatt* and Jovita Kanoujia*


DOI: 10.2174/1573408016666200324152018


Review Article

Development of steroidal aromatase inhibitors as potential anti-breast cancer agents

, 2020; 16(1): 45-62.

Rahul B. Ghuge, Prashant R. Murumkar, Kailash M. Choudhary, Karan D. Joshi, Monica Chauhan, Rahul R. Barot and Mange R. Yadav*


DOI: 10.2174/1573408016666200212094804


Review Article

The role of stat3 signaling in different types of cancers: A compre-hensive review

, 2020; 16(3): 189-198.

Kaviarasan Lakshmanan, Gowramma Byran*, Sravanthi Bandlamudi and Praveen Thaggikuppe Krishnamurthy


DOI: 10.2174/1573408016999200708160300


Review Article (Mini-Review)

Perspective on acetylcholinesterase: A potential target for alzheimer’s disease intervention

, 2020; 16(3): 181-188.

Rajesh Basnet*, Sandhya Khadka*, Buddha Bahadur Basnet and Radheshyam Gupta


DOI: 10.2174/1573408016999200801021329


Research Article

Carbon nanotubes inhibit the pepsin activity at high ionic strength

, 2020; 16(3): 251-257.

Khlowd M. Jasem, Hussein K. Al-Hakeim* and Jawad K. Al-Shams


DOI: 10.2174/1573408016999200603170618






Most Accessed Articles







In Silico Investigation: Opening Doors to Novel Thymidylate Synthase Inhibitors

, 2020; 16(3): 224-237.

Sheenu Mittal, Ankit Gupta, Monika, Richa, Renu Chadha and Neelima Dhingra*


DOI: 10.2174/1573408016999200602130121


The Role of STAT3 Signaling in Different Types of Cancers: A Comprehensive Review

, 2020; 16(3): 189-198.

Kaviarasan Lakshmanan, Gowramma Byran*, Sravanthi Bandlamudi and Praveen Thaggikuppe Krishnamurthy


DOI: 10.2174/1573408016999200708160300




Carbon Nanotubes Inhibit the Pepsin Activity at High Ionic Strength

, 2020; 16(3): 251-257.

Khlowd M. Jasem, Hussein K. Al-Hakeim* and Jawad K. Al-Shams


DOI: 10.2174/1573408016999200603170618




Enzyme Inhibition, Kinetic, and Molecular Docking Studies of α-glucosidase

, 2020; 16(2): 155-161.

Ebrahim S. Moghadam, Mohammad A. Faramarzi, Somayeh Imanparast and Mohsen Amini*


DOI: 10.2174/1573408016999200415115009


Role of Cytochrome P450 in Prostate Cancer and its Therapy

, 2020; 16(1): 63-73.

Rishabh Kaushik, Sheeza Khan, Meesha Sharma, Srinivasan Hemalatha, Zeba Mueed and Nitesh K. Poddar*


DOI: 10.2174/1573408016666200218122044



Editor-in-Chief

graphic
Claudiu T. Supuran
(83932 citations)
University of Florence
Florence
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Enzyme Inhibition Journal was launched in 2005. Dr. Claudiu T. Supuran serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog